Today: 9 June 2026
MACOM stock jumps nearly 5% as MTSI swings sharply ahead of Feb. 5 earnings
2 February 2026
1 min read

MACOM stock jumps nearly 5% as MTSI swings sharply ahead of Feb. 5 earnings

New York, February 2, 2026, 12:52 (EST) — Regular session

  • MACOM shares climbed roughly 5% by midday, bouncing back from a sharp intraday swing
  • Ahead of Thursday’s pre-market release, investors are gearing up for MACOM’s quarterly earnings report
  • Chip stocks hold steady as the semiconductor ETF edges up on the day

Shares of MACOM Technology Solutions Holdings climbed 4.9% to $229.72 by midday Monday, having fluctuated between $206.84 and $236.15 earlier. Trading volume exceeded 980,000 shares, with the stock up $10.66 from the previous close.

This move is significant, arriving amid a packed earnings week for U.S. tech and mere days ahead of MACOM’s own earnings and outlook update. Given how swiftly the stock has been shifting, the forthcoming guidance could have an even bigger impact than the quarterly results themselves.

It felt more like positioning than a direct response. Traders have been piling into chip stocks linked to faster networking and high-frequency parts, yet they’re ready to cut exposure just as fast if sentiment shifts.

Semiconductor shares climbed broadly, pushing the iShares Semiconductor ETF up roughly 2.4% by midday.

MACOM announced it will release its fiscal first-quarter results on Feb. 5 ahead of the market open, with a conference call scheduled for the same morning.

The company’s investor relations calendar schedules the call for 8:30 a.m. Eastern and directs investors to a live webcast along with replay information.

MACOM develops and produces high-performance semiconductor products serving data centers, telecommunications, and industrial and defense sectors, according to its company profile.

Shares hovering near recent peaks, investors are keen to catch any sign of demand beyond “steady,” particularly in segments prone to sudden order spikes. Margins and product mix comments will be under the microscope, as even minor shifts could alter the earnings trajectory.

That said, the setup works both ways. Following a rally that attracted momentum buyers, any hint of caution or weaker order flow could spark a sharp pullback, even if the quarterly results appear solid.

Stock Market Today

  • Jim Cramer's Top 10 Market Watch Points for June 9
    June 9, 2026, 9:57 AM EDT. Jim Cramer's top 10 things to watch on June 9 include U.S. stocks rebounding after a selloff, supported by lower oil prices and bond yields. The SpaceX IPO is heavily oversubscribed, expected to start trading Friday, while OpenAI filed confidentially for its IPO with a potential trillion-dollar valuation. Anthropic secured a $35 billion debt deal to fund its AI growth. TD Cowen raised its Alphabet price target to $475 amid margin optimism, despite dilution concerns. Amazon issued a $10 billion Canadian dollar bond, the largest in that currency. China plans to invest $295 billion in AI data centers over five years. Micron is expected to beat earnings guidance, while Apple shares face pressure despite AI enhancements. GSK's $10.6 billion acquisition of Nuvalent lifts shares, highlighting moves in the healthcare sector.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
CoreWeave stock slips as class-action notices pile up ahead of earnings
Previous Story

CoreWeave stock slips as class-action notices pile up ahead of earnings

Cisco stock pops to a fresh 52-week high — here’s what Wall Street is watching next
Next Story

Cisco stock pops to a fresh 52-week high — here’s what Wall Street is watching next

Go toTop